IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why
https://www.zacks.com/stock/news/2210645/igm-bio-igms-stock-rallies-142-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2210645
Jan 16, 2024 - IGM Bio (IGMS) stock surges 142% in the past three months on strategic reprioritization efforts to focus its resources on the development of pipeline candidates for cancer and autoimmune indications.
0
Sanofi (SNY) Presents at J.P. Morgan 42nd Annual Healthcare Conference Call Transcript
https://seekingalpha.com/article/4662029-sanofi-sny-presents-j-p-morgan-42nd-annual-healthcare-conference-call-transcript?source=feed_sector_transcripts
Jan 09, 2024 - Sanofi (NASDAQ:NASDAQ:SNY) J.P. Morgan 42nd Annual Healthcare Conference Call January 9, 2024 1:30 PM ETCompany ParticipantsPaul Hudson - Chief Executive...
0
Top Research Reports for Meta Platforms, Broadcom & Verizon
https://www.zacks.com/commentary/2206970/top-research-reports-for-meta-platforms-broadcom-verizon?cid=CS-ZC-FT-research_daily-2206970
Jan 09, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Broadcom Inc. (AVGO) and Verizon Communications Inc. (VZ).
0
Warning: SNY is at high risk of cutting its dividend
https://seekingalpha.com/warnings/4052831-warning-sny-is-high-risk-of-cutting-dividend?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jan 07, 2024 - Sanofi (NASDAQ:SNY) has displayed warning signs that have historically led to dividend cuts. The company has a Dividend Safety Score of F.
0
Pharma Stock Roundup: LLY's New Digital Pharmacy, NVO & ABBV's Fresh R&D Deals
https://www.zacks.com/stock/news/2206363/pharma-stock-roundup-lly-s-new-digital-pharmacy-nvo-abbv-s-fresh-r-d-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2206363
Jan 05, 2024 - Eli Lilly (LLY) launches a new direct-to-consumer website to provide easy access to its medicines. Novo Nordisk (NVO) announces two research collaborations to develop novel treatments for cardiometabolic diseases.
0
Here's Why Sanofi (SNY) is a Strong Value Stock
https://www.zacks.com/stock/news/2204141/here-s-why-sanofi-sny-is-a-strong-value-stock?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2204141
Jan 01, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
https://www.zacks.com/stock/news/2201634/sanofi-sny-discontinues-tusamitamab-ravtansine-cancer-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201634
Dec 22, 2023 - Sanofi (SNY) stops the development of tusamitamab ravtansine after a phase III study on the candidate for second-line metastatic non-small cell lung cancer fails to meet the primary endpoint.
0
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
https://www.zacks.com/stock/news/2201507/pharma-stock-roundup-fda-nod-to-azn-s-eplontersen-crl-to-mrk-s-cough-candidate?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201507
Dec 22, 2023 - FDA approves AstraZeneca (AZN) and Ionis' (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Merck's chronic cough candidate, gefapixant.
0
Top Analyst Reports for Alphabet, Comcast & NextEra Energy
https://www.zacks.com/commentary/2201007/top-analyst-reports-for-alphabet-comcast-nextera-energy?cid=CS-ZC-FT-research_daily-2201007
Dec 21, 2023 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Comcast Corp. (CMCSA) and NextEra Energy, Inc. (NEE).
0
3 Stocks to Buy Before 2024 That Can Set You Up For Life
https://www.fool.com/investing/2023/12/14/3-stocks-to-buy-before-2024-that-can-set-you-up/?source=iedfolrf0000001
Dec 14, 2023 - These stocks are still relatively cheap, but don't expect them to stay that way for long.
0